Trial
NCT04649411
Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Keryx Biopharmaceuticals
Collaborators
—
Condition
Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Intervention
ferric citrate
Why stopped
PMR release
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-20